The sustained effects of extending cardiac rehabilitation with a six-month telemonitoring and telecoaching programme on fitness, quality of life, cardiovascular risk factors and care utilisation in CAD patients: The TeleCaRe study.

Autor: Snoek JA; Authors contributed equally to the study. Isala Heart Centre, Zwolle, The Netherlands.; Sports Medicine Department, Isala, Zwolle, The Netherlands., Meindersma EP; Authors contributed equally to the study. Isala Heart Centre, Zwolle, The Netherlands.; Cardiology Department, Radboud UMC, Nijmegen, The Netherlands., Prins LF; Diagram, Zwolle, The Netherlands., Van't Hof AW; Cardiology Department, Maastricht UMC, Maastricht, The Netherlands.; Cardiology Department, Zuyderland MC, Heerlen, The Netherlands., de Boer MJ; Cardiology Department, Radboud UMC, Nijmegen, The Netherlands., Hopman MT; Radboud Institute for Health Sciences, Department of Physiology, Radboud University Medical Centre, Nijmegen, The Netherlands., Eijsvogels TM; Radboud Institute for Health Sciences, Department of Physiology, Radboud University Medical Centre, Nijmegen, The Netherlands., de Kluiver EP; Authors contributed equally to the study. Isala Heart Centre, Zwolle, The Netherlands.
Jazyk: angličtina
Zdroj: Journal of telemedicine and telecare [J Telemed Telecare] 2021 Sep; Vol. 27 (8), pp. 473-483. Date of Electronic Publication: 2019 Nov 23.
DOI: 10.1177/1357633X19885793
Abstrakt: Introduction: The aim of this study was to assess the acute and sustained effects of a six-month heart-rate-based telerehabilitation programme, following the completion of cardiac rehabilitation (CR), on peak oxygen uptake (peakVO 2 ), quality of life (QoL), cardiovascular risk factors and care utilisation in patients with coronary artery disease (CAD).
Methods: A total of 122 patients with CAD were randomised, after the completion of CR, to an intervention group with six months of telemonitoring and telecoaching (TELE) or a control group with a traditional six-month follow-up programme with monthly calls (CON). The primary outcome was peakVO 2 at 12 months, to assess the sustained effects of TELE. The secondary outcomes included QoL, cardiovascular risk factors (lipid spectrum), major adverse cardiovascular events (MACE) and habitual physical activity.
Results: PeakVO 2 increased significantly from baseline to 12 months in TELE (+2.5 mL·kg -1 min -1 (95% CI 1.5-3.2)) and CON (+1.9 mL·kg -1 min -1 (95% CI 1.0-2.5)), and did not differ between groups (P = 0.28). Similarly, QoL (P = 0.31), total cholesterol (P = 0.45), MACE (P = 0.86) did not differ between groups and in time.
Discussion: Extending CR with a heart-rate-based telerehabilitation programme did not yield additional sustainable health benefits compared with regular care with monthly telephone calls. These observations highlight that both telerehabilitation and regular care with monthly telephone calls may prevent the typically observed reductions in peakVO 2 following the completion of a CR programme.Trial registration: Dutch Trial Register NL4140 (registered 6 December 2014).
Databáze: MEDLINE